Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $1.5 billion.

  • Haemonetics' Total Non-Current Liabilities fell 121.29% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year decrease of 121.29%. This contributed to the annual value of $1.6 billion for FY2025, which is 3457.95% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Total Non-Current Liabilities is $1.5 billion, which was down 121.29% from $1.5 billion recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Total Non-Current Liabilities peaked at $1.6 billion during Q1 2025, and registered a low of $976.2 million during Q3 2022.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $1.1 billion (2022), whereas its average is $1.2 billion.
  • Over the last 5 years, Haemonetics' Total Non-Current Liabilities had its largest YoY gain of 10419.49% in 2022, and its largest YoY loss of 428.56% in 2022.
  • Over the past 5 years, Haemonetics' Total Non-Current Liabilities (Quarter) stood at $1.0 billion in 2021, then grew by 1.26% to $1.0 billion in 2022, then rose by 15.33% to $1.2 billion in 2023, then increased by 29.94% to $1.5 billion in 2024, then fell by 1.21% to $1.5 billion in 2025.
  • Its Total Non-Current Liabilities stands at $1.5 billion for Q4 2025, versus $1.5 billion for Q3 2025 and $1.5 billion for Q2 2025.